RKT vs SRPT · rev $5.72B vs rev $1.13B
Rocket Companies Inc (RKT) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Rocket Companies Inc (RKT) is a mortgage finance company listed on NYSE.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported RKT revenue for 2026-06-30 was $5.72B. Net income was $527.0M. Revenue was up 94.7% from 2026-03-31 to 2026-06-30. RKT currently screens at market cap $40.62B.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
RKT currently screens at market cap $40.62B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the RKT and SRPT stock pages for the full models.
Not investment advice.